Gilead Sciences (NASDAQ: GILD) is an American biotechnology that researches, develops, and commercializes drugs. The company is best known for curing Hepatitis C, however, they have a portfolio of impressive assets. As we’ll see throughout this article, the company’s impressive financial performance and major upcoming catalysts mandate investing in this company.
Gilead Sciences - Med City News
Gilead Sciences' Impressive Financial Performance
Gilead Sciences has continued to perform quite well financially, which is impressive for shareholders. The company’s dividend yield is approaching 4%.
Gilead Sciences Financials - Gilead Sciences Investor Presentation
The company has